Average cost of drugs for extensively drug-resistant tuberculosis in Zimbabwe
Zimbabwe: Average cost of drugs for extensively drug-resistant tuberculosis was 852 constant 2022 US$ in 2023. ◆ Volatile
Latest (2023)
852 constant 2022 US$
Change on year
down 39.1%
World rank
45th
of 56 countries
All-time high
12,462 constant 2022 US$
in 2017
All-time low
500 constant 2022 US$
in 2020
Years of data
6
2017–2023
Average cost of drugs for extensively drug-resistant tuberculosis in Zimbabwe, 2017–2023
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of drugs for extensively drug-resistant tuberculosis in Zimbabwe is 852 constant 2022 US$, measured in 2023.
Compared with earlier readings it is down 39.1% on the previous year and down 93.2% over ten years.
That places Zimbabwe 45th out of 56 countries with data for 2023, putting it in the bottom quarter.
Average cost of drugs for extensively drug-resistant tuberculosis in Zimbabwe, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 12,462 constant 2022 US$ | — |
| 2018 | 4,762 constant 2022 US$ | -61.8% |
| 2019 | 9,774 constant 2022 US$ | +105.2% |
| 2020 | 500 constant 2022 US$ | -94.9% |
| 2022 | 1,400 constant 2022 US$ | +180.0% |
| 2023 | 852 constant 2022 US$ | -39.1% |
Zimbabwe compared with similar countries
- Zimbabwe's 852 constant 2022 US$ is below the median for lower middle income countries, which is 1,525 constant 2022 US$, 56% of the median. (24 countries reporting)
- Zimbabwe's 852 constant 2022 US$ is below the median for Sub-Saharan Africa, which is 1,500 constant 2022 US$, 57% of the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 8,999 constant 2022 US$ | 4,762 constant 2022 US$ | 12,462 constant 2022 US$ | 3 |
| 2020s | 917.33 constant 2022 US$ | 500 constant 2022 US$ | 1,400 constant 2022 US$ | 3 |
Countries ranked near Zimbabwe
More reference data data for Zimbabwe
- Exchange rate, new LCU per USD extended backward, period average 58,959 (2026)
- Exchange rate, old LCU per USD extended forward, period average 58,959 (2026)
- Official exchange rate, LCU per USD, period average 58,959 (2026)
- Political opposition, annual growth rate 0 % change on previous year (2025)
- Elected parliament and government, annual growth rate 0 % change on previous year (2025)
- Global number of reported disasters by size, gaps filled 0 events (2024)
- Annual precipitation, annual growth rate 122.78 % change on previous year (2025)
- Free country, gaps filled 0 (2025)
- Civil liberties rating, gaps filled 5 (2025)
- Civil liberties rating, annual growth rate 0 % change on previous year (2025)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Zimbabwe?
- Average cost of drugs for extensively drug-resistant tuberculosis in Zimbabwe was 852 constant 2022 US$ in 2023, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Zimbabwe?
- The highest recorded value was 12,462 constant 2022 US$ in 2017.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Zimbabwe?
- The lowest recorded value was 500 constant 2022 US$ in 2020.
- How does Zimbabwe rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Zimbabwe ranks 45th out of 56 countries with data for 2023.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Zimbabwe?
- Over the last ten years it is down 93.2%. The long-run trend across the full record is volatile.
- Where does this Zimbabwe data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.